Agilent Technologies' New Genome Analysis Technology Set to Accelerate Australia's Fight Against Mesothelioma.

Business WireApril 14, 2005

Linked as:

Extract


Agilent Technologies' New Genome Analysis Technology Set to Accelerate Australia's Fight Against Mesothelioma.

MELBOURNE, Australia -- Agilent Technologies Inc. (NYSE:A) today announced that its breakthrough Human Genome CGH Microarray technology will be us...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company